Business · 08/12/2011
NIH to Grant Exclusive License for Cancer Treatment Inventions
The National Institutes of Health (NIH) is considering granting a worldwide exclusive license to practice inventions targeting thrombospondin-1 and CD47 to treat radiation-induced damage and enhance radiotherapy effectiveness in cancer patients, based on provisional patent applications filed between 2006 and 2009.